Neural Stem Cell Institute, Rensselaer NY 12144, USA.
Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Stem Cell Reports. 2020 Apr 14;14(4):631-647. doi: 10.1016/j.stemcr.2020.03.009. Epub 2020 Apr 2.
Epithelial to mesenchymal transition (EMT) is a biological process involved in tissue morphogenesis and disease that causes dramatic changes in cell morphology, migration, proliferation, and gene expression. The retinal pigment epithelium (RPE), which supports the neural retina, can undergo EMT, producing fibrous epiretinal membranes (ERMs) associated with vision-impairing clinical conditions, such as macular pucker and proliferative vitreoretinopathy (PVR). We found that co-treatment with TGF-β and TNF-α (TNT) accelerates EMT in adult human RPE stem cell-derived RPE cell cultures. We captured the global epigenomic and transcriptional changes elicited by TNT treatment of RPE and identified putative active enhancers associated with actively transcribed genes, including a set of upregulated transcription factors that are candidate regulators. We found that the vitamin B derivative nicotinamide downregulates these key transcriptional changes, and inhibits and partially reverses RPE EMT, revealing potential therapeutic routes to benefit patients with ERM, macular pucker and PVR.
上皮间质转化(EMT)是一个涉及组织形态发生和疾病的生物学过程,它导致细胞形态、迁移、增殖和基因表达的剧烈变化。视网膜色素上皮(RPE),支持神经视网膜,可以经历 EMT,产生与视力损害的临床情况相关的纤维性视网膜前膜(ERM),如黄斑皱襞和增生性玻璃体视网膜病变(PVR)。我们发现,TGF-β和 TNF-α(TNT)的共同处理加速了成人人类 RPE 干细胞衍生的 RPE 细胞培养物中的 EMT。我们捕捉到了 TNT 处理 RPE 引起的全基因组表观遗传和转录变化,并确定了与活跃转录基因相关的潜在活性增强子,包括一组上调的转录因子,它们是候选调节剂。我们发现维生素 B 衍生物烟酰胺下调这些关键的转录变化,并抑制和部分逆转 RPE EMT,为患有 ERM、黄斑皱襞和 PVR 的患者提供潜在的治疗途径。